First Time Loading...

IQVIA Holdings Inc

Watchlist Manager
IQVIA Holdings Inc Logo
IQVIA Holdings Inc
Price: 196.75 USD -0.48% Market Closed
Updated: Oct 1, 2023

Intrinsic Value

Intrinsic Value History
IQVIA Holdings Inc

Whether you're assessing long-term stability or short-term opportunities, Historical Valuation serves as a vital tool to enhance your investment approach, enabling you to make more informed investment decisions.

This feature available only with
Unlimited Plan

Sign up to access IQVIA Holdings Inc's intrinsic value history.

No restrictions, no limits.
All stocks, all tools.

Spot Contrarian Opportunities

Look for stocks that have been historically overvalued but are now trading below their intrinsic value.

Easily Identify Value Traps

Avoid stocks that are always undervalued and never reach their intrinsic value.

Find Strong Rebounds

Find stocks that have historically corrected quickly from being undervalued to reaching their intrinsic value.

Valuation Methods

There are two methods to calculate the Intrinsic Value of a stock: DCF Valuation and Relative Valuation. We take the average of these two methods to estimate the intrinsic value as accurately as possible. You can see the Intrinsic Value of a stock at the top of this page.

DCF Value
Discounted Cash Flow

DCF Parameters:
Operating Model
Discount Rate
Forecast Period
Terminal Growth
DCF Input
DCF Input
DCF Input

Fundamental Analysis


Balance Sheet Decomposition
IQVIA Holdings Inc

Current Assets 5.3B
Cash & Short-Term Investments 1.5B
Receivables 3.2B
Other Current Assets 653m
Non-Current Assets 20.7B
Long-Term Investments 208m
PP&E 829m
Intangibles 19.1B
Other Non-Current Assets 550m
Current Liabilities 6.5B
Accounts Payable 3B
Other Current Liabilities 3.5B
Non-Current Liabilities 13.7B
Long-Term Debt 12.4B
Other Non-Current Liabilities 1.3B
Fundamental Scores

IQV Profitability Score
Profitability Due Diligence

IQVIA Holdings Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Positive Gross Profit
ROE is Increasing
Positive 3-Years Revenue Growth

IQVIA Holdings Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

IQV Solvency Score
Solvency Due Diligence

IQVIA Holdings Inc's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
High D/E

IQVIA Holdings Inc's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IQV Price Targets Summary
IQVIA Holdings Inc

Wall Street analysts forecast IQV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IQV is 255.86 USD with a low forecast of 217.15 USD and a high forecast of 295.05 USD.

Price Target
217.15 USD
10% Upside
Price Target
255.86 USD
30% Upside
Price Target
295.05 USD
50% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape


IQV Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

IQV Return Decomposition
Main factors of price return

What is price return decomposition?

IQV Price
IQVIA Holdings Inc

1M 1M
6M 6M
1Y 1Y
3Y 3Y
5Y 5Y
10Y 10Y
Annual Price Range
52w Low
52w High
Price Metrics
Average Annual Return 23.14%
Standard Deviation of Annual Returns 29.13%
Max Drawdown -49%
Shares Statistics
Market Capitalization 36B USD
Shares Outstanding 185 549 000
Percentage of Shares Shorted 1.96%

IQV News

Last Video News
IQVIA Holdings Inc

Other Videos

Company Profile

IQVIA Holdings Inc Logo
IQVIA Holdings Inc


United States of America


Life Sciences Tools & Services

Market Cap


Dividend Yield



IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. The company is headquartered in Durham, North Carolina and currently employs 79,000 full-time employees. The company went IPO on 2013-05-09. The Company’s segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. Technology & Analytics Solutions provides critical information, technology solutions and real-world insights and services to its life science clients. Research & Development Solutions, which primarily serves biopharmaceutical clients, is engaged in research and development and provides clinical research and clinical trial services. Contract Sales & Medical Solutions provides contract sales to both biopharmaceutical clients and the broader healthcare market.


4820 Emperor Blvd




79 000


Chairman, Pres & CEO
Mr. Ari Bousbib
Exec. VP & CFO
Mr. Ronald E. Bruehlman
Exec. VP, Gen. Counsel & Sec.
Mr. Eric M. Sherbet
Pres of Corp. Strategy & Enterprise Networks
Mr. Kevin C. Knightly
Sr. VP, Corp. Controller & Principal Accounting Officer
Ms. Keriann Cherofsky
Sr. VP, Global Chief Medical & Scientific Officer
Dr. Jeffrey A. Spaeder
Show More
Sr. VP & Chief Information Officer
Mr. Karl Guenault
Sr. VP of Investor Relations
Andrew Markwick
Sr. VP, Investor Relations & Corp. Communications
Mr. Nicholas Childs
Chief HR Officer & Exec. VP
Ms. Trudy Stein
Show Less

See Also

Other Stocks
What is the Intrinsic Value of one IQV stock?

The intrinsic value of one IQV stock under the Base Case scenario is 287.97 USD.

Is IQV stock undervalued or overvalued?

Compared to the current market price of 196.75 USD, IQVIA Holdings Inc is Undervalued by 32%.